Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

The conundrum of depression clinical trials: one size does not fit all

Open access
Khan, Arif, Mar, Kaysee Fahl, Brown, Walter A. · 2018 · International Clinical Psychopharmacology

Abstract

In this paper we review the history of antidepressant (AD) development, since the discovery of imipramine in 1957 to the present day. Through this exploration we will show that the increasing placebo response is likely a red herring and that a higher magnitude of placebo response is not an adequate explanation for AD trials' high failure rates. As a better explanation for their lack of success, we will examine some of the fundamental flaws of AD clinical trials and their origins in historical forces. We focus on underpowering, which occurs as a consequence of unrealistic expectations for AD performance. In addition, we describe the lack of precision in the depression outcome measurements for the past 40 years and show how these measures contrast with those used in clinical trials of other chronic diseases, which use simpler outcome measures. Finally, we describe the role of regulatory agencies in influencing clinical trial design and how the assumption that 'one size fits all' for the past 60 years has led to flawed design of AD clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/yic.0000000000000229

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Funnel plot of placebo response plotted with placebo arm sample size. Dotted line represents the median split of placebo arm N (87 N: an unbiased threshold used to examine the differential effects of smaller and larger sample sizes).
Fig. 1 Funnel plot of placebo response plotted with placebo arm sample size. Dotted line represents the median split of placebo arm N (87 N: an unbiased threshold used to examine the differential effects of smaller and larger sample sizes).CC BY-NC-ND · PubMed Central
Fig. 2 Co-occurrence of 52 depression symptoms across seven depression rating scales. Colored circles for a symptom indicate that a scale directly assesses that symptom, while empty circles indicate that a scale only measures a symptom indirectly. For instance, the IDS assesses item 4 hypersomnia directly; the BDI measures item 4 indirectly by a general question on sleep problems; and the SDS does not capture item 4 at all. Note that the nine QIDS items analyzed correspond exactly to the DSM-5 criterion symptoms for MDD. BDI, 21-item Beck Depression Inventory-II; CESD, Center for Epidemiologic Studies Depression Scale; DSM-5, Diagnostic and Statistical Manual, 5th ed.; HRSD, Hamilton Rating Scale for Depression; IDS, Inventory of Depressive Symptoms; MADRS, Montgomery-Asberg Depression Rating Scale; SDS, Zung Self-Rating Depression Scale; QIDS, Quick Inventory of Depressive Symptoms. Reprinted from: Fried (2017). Copyright [Elsevier], [Amsterdam, Netherlands]. All permission requests for this image should be made to the copyright holder.
Fig. 2 Co-occurrence of 52 depression symptoms across seven depression rating scales. Colored circles for a symptom indicate that a scale directly assesses that symptom, while empty circles indicate that a scale only measures a symptom indirectly. For instance, the IDS assesses item 4 hypersomnia directly; the BDI measures item 4 indirectly by a general question on sleep problems; and the SDS does not capture item 4 at all. Note that the nine QIDS items analyzed correspond exactly to the DSM-5 criterion symptoms for MDD. BDI, 21-item Beck Depression Inventory-II; CESD, Center for Epidemiologic Studies Depression Scale; DSM-5, Diagnostic and Statistical Manual, 5th ed.; HRSD, Hamilton Rating Scale for Depression; IDS, Inventory of Depressive Symptoms; MADRS, Montgomery-Asberg Depression Rating Scale; SDS, Zung Self-Rating Depression Scale; QIDS, Quick Inventory of Depressive Symptoms. Reprinted from: Fried (2017). Copyright [Elsevier], [Amsterdam, Netherlands]. All permission requests for this image should be made to the copyright holder.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Research works printed but not linked: 2

  1. Demitrack, 1998, Psychopharmacol Bull, 34, 19
  2. Khan, 2003a, J Nerv Ment Dis, 191, 211

Cited by

See all 33

Metadata

Authors
Khan, A., Mar, K. F., & Brown, W. A.
Affiliations
  • Duke University (US)
  • Northwest Clinical Research Center (US)
  • Brown University (US)
Corresponding author
Khan, Arif
Venue
International Clinical Psychopharmacology
Published
2018-09
Volume
33
Issue
5
Pages
239-248
ISSN
0268-1315 (ISSN-L)
OpenAlex
W2808933129
Cited by
30
References
61
Citations by year
2025: 6 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 6 · 2020: 6 · 2019: 5
FWCI
0.50
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • International Clinical Psychopharmacology (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Biomedical Research Council
  • NIH Clinical Center
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
Keywords
antidepressant drug development, placebo response, underpowered trials, imipramine, history of antidepressants
MeSH terms
Antidepressive Agents, Clinical Trials as Topic, Depressive Disorder, Humans, Imipramine, Placebos, History, 20th Century, History, 21st Century

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The conundrum of depression clinical trials: one size does not fit all. https://app.cochat.ai/papers/10.1097/yic.0000000000000229
The paper
Khan, A., Mar, K. F., & Brown, W. A. (2018). The conundrum of depression clinical trials: one size does not fit all. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0000000000000229

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.